Clik here to view.
InVivo Therapeutics adds patient to Inspire spinal scaffold trial
InVivo Therapeutics (NSDQ:NVIV) said today it added a new patient to the Inspire study of its neuro-spinal scaffold. The Cambridge, Mass.-based company’s neuro-spinal scaffold is designed to be...
View ArticleClik here to view.
Xenocor wins CE Mark for low cost Xenoscope laparoscope
Laparoscopic device developer Xenocor said today it won CE Mark approval in the European Union for its single-use Xeonoscope laparoscopic systems. The Salt Lake City, Utah-based company touted the...
View ArticleClik here to view.
Compliance with ISO 14155:2011
IMARC Research has created a new whitepaper that highlights the Guidance for Ensuring your Clinical Study is Being Designed, Executed, and Monitored in Accordance with the ISO 14155.2011 International...
View ArticleClik here to view.
Aethlon’s blood filtration device as broad countermeasure for infectious...
In the midst of a devastating global crisis 2 years ago, a Ugandan physician was infected with Ebola in Sierra Leone as he was treating patients. He was hospitalized at the Frankfurt University...
View ArticleClik here to view.
Report finds pressure from Congress does not budge drug prices
Committees in Congress have issued more than a dozen subpoenas to drug-makers for alleged price-hiking in the last 2 years, with members of the House and Senate collecting hundreds of thousands of...
View ArticleClik here to view.
PixarBio raises $7m for non-addictive morphine alternative
PixarBio (OTC:PXRB) raised $7 million for its biomaterial-based opioid alternative for post-operative acute and chronic pain relief, about 18% of its $40 million equity financing according to a...
View ArticleClik here to view.
Mallinckrodt touts data for Ofirmev injected acetaminophen
Mallinckrodt Pharmaceuticals (NYSE:MNK) today released results from a clinical pharmacokinetic study evaluating the effect of IV morphine on the absorption of oral acetaminophen, touting the...
View ArticleClik here to view.
Micell Technologies raises $26m
Micell Technologies raised $25.8 million in a new round of equity and debt financing, according to an SEC filing posted this week. Micell currently produces the MiStent SES sirolimus eluting absorbable...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for November 18, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
Myomo registers for IPO
Myomo said today it filed with the SEC for an initial public offering, looking to register on the NYSE under the ticker symbol “MYO”. Myomo develops and produces myoelectric orthotics for patients with...
View ArticleClik here to view.
Athenex, Lilly ink clinical collaboration for 1st oral formulation of paclitaxel
Athenex said today that it inked a clinical collaboration deal to conduct a phase Ib study for its oral form of paclitaxel, Oraxol, with Eli Lilly‘s (NYSE:LLY) vascular endothelial growth factor (VEGF)...
View ArticleClik here to view.
Restoring blood vessels to tumor cells aids delivery of chemotherapy
Researchers from the Flanders Institute for Biotechnology in Belgium say they have found a way to repair dysfunctional blood vessels which allow cancer cells to escape from the blood stream and reach...
View ArticleClik here to view.
Seventh Sense raises $10m in Series C
Seventh Sense Biosystems said today it raised $10 million in a Series C funding round to support its Tap push-button blood collection device, as well as new product development and increasing...
View ArticleClik here to view.
GE Healthcare, UCSF launch ‘deep learning’ project
GE Healthcare (NYSE:GE) and the University of California San Francisco said today they inked partnership, looking to develop a library of deep learning algorithms to aid clinicians in making more...
View ArticleClik here to view.
NovoCure touts long-term analysis for Optune TTF, drug combo in brain cancer
NovoCure (NSDQ:NVCR) today released long-term analysis data from the phase 3 pivotal EF-14 trial of its Optune device in combination with temozolomide for treating newly diagnosed glioblastoma, touting...
View ArticleClik here to view.
Novo Nordisk, Sanofi win FDA nods for diabetes drugs
Both Novo Nordisk (NYSE:NVO) and Sanofi (NYSE:SNY) said yesterday that they won FDA approval for pre-filled pens with drug combinations indicated for adults with Type II diabetes. Paris-based Sanofi’s...
View ArticleClik here to view.
Boston Scientific closes $210m EndoChoice buy
Boston Scientific (NYSE:BSX) said today that it closed its $210 million buyout of EndoChoice (NYSE:GI) and its line of devices for treating gastrointestinal disease. The $8-per-share tender offer was...
View ArticleClik here to view.
FDA clears Allergan’s Xen gel stent for glaucoma
Allergan (NYSE:AGN) said today that it won FDA approval for its Xen gel stent and injector for glaucoma. The federal watchdog indicated the drug device for the management of refractory glaucoma, in...
View ArticleClik here to view.
Mylan declines to testify at Senate committee hearing
Mylan (NDSQ:MYL) declined to testify at a U.S. Senate committee regarding its $465 million pending settlement to deal with charges that it underpaid government healthcare programs when it...
View ArticleClik here to view.
Corvia Medical touts 1-year data for InterAtrial shunt
Corvia Medical today released 1-year results from the Reduce LAP-HF clinical trial of its InterAtrial shunt device, touting a good safety profile and sustained device performance. Results from the...
View Article
